Tesser Co., Ltd.

Founded in 2019 and based in Seoul, South Korea, Tesser Co. , Ltd. operates an artificial intelligence software platform that translates complex medical jargon found in patient reports into simple terms. In August 2023, Tesser Inc.

raised seed funding from Korea Tech Incubator for Startup, being selected for Accelerator Investment-Driven Tech Incubator Program. As of 2023, Lee Soo-hyun serves as the CEO of the company and has worked with more than 15 partner companies, hospitals, and research institutes. The company's flagship product, Ontol, is a patient-data-driven next-generation medical platform that simplifies the understanding of test result sheets, opinions, and diagnosis records while also offering visualization of medical images. The firm’s platform enables patients to easily access and understand complex medical information, as well as receive online consultations from multiple doctors.

Patients can ask questions and receive answers from medical personnel, leveraging their own data. Tesser offers advanced analysis and interpretation of medical imaging data powered by a 3D deep learning medical image processing engine. This technology allows for tumour analysis, tracking changes, and identifying potential functional issues, aiding in the prompt identification of appropriate treatments. The company will use the TIPS funding to advance research and development of 3D visualization AI technology to facilitate the interpretation of medical images and test result sheets.